Although tumour tissue, such as that obtained by surgical resection or transbronchial biopsy, has usually been used for analysis of EGFR mutations in lung cancer, a small number of patients with NSCLC can be diagnosed purely on the basis of cytology using small numbers of cancer cells. This evidence concerns the gene EGFR and cancer.